Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea
· Delayed Price · Currency is KRW 14,070
+110 (0.79%)
At close: Mar 6, 2026
Cell Biotech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 93,077 | 97,662 | 76,789 | 86,918 | 133,300 | 166,285 | Upgrade
|
| Market Cap Growth | -2.23% | 27.18% | -11.65% | -34.80% | -19.84% | 21.02% | Upgrade
|
| Enterprise Value | 4,696 | 19,190 | 10,612 | 22,959 | 70,193 | 110,107 | Upgrade
|
| Last Close Price | 13600.00 | 13643.66 | 10388.77 | 11289.59 | 16183.18 | 19689.82 | Upgrade
|
| PE Ratio | 7.39 | 6.46 | 12.18 | 10.50 | 12.84 | 52.14 | Upgrade
|
| Forward PE | - | 8.16 | 8.16 | 8.16 | 8.16 | 8.16 | Upgrade
|
| PS Ratio | 1.84 | 1.96 | 1.43 | 1.72 | 2.84 | 3.65 | Upgrade
|
| PB Ratio | 0.73 | 0.79 | 0.69 | 0.80 | 1.25 | 1.66 | Upgrade
|
| P/TBV Ratio | 0.74 | 0.80 | 0.70 | 0.82 | 1.27 | 1.69 | Upgrade
|
| P/FCF Ratio | 11.10 | 5.38 | 12.26 | 8.32 | 9.49 | 25.64 | Upgrade
|
| P/OCF Ratio | 8.01 | 5.07 | 9.82 | 6.78 | 8.95 | 17.39 | Upgrade
|
| EV/Sales Ratio | 0.09 | 0.38 | 0.20 | 0.45 | 1.50 | 2.42 | Upgrade
|
| EV/EBITDA Ratio | 0.49 | 1.80 | 1.74 | 2.37 | 6.36 | 14.98 | Upgrade
|
| EV/EBIT Ratio | 0.78 | 2.82 | 4.83 | 3.79 | 9.67 | 30.03 | Upgrade
|
| EV/FCF Ratio | 0.56 | 1.06 | 1.69 | 2.20 | 5.00 | 16.98 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.06 | 0.10 | 0.25 | 0.10 | 0.07 | 0.18 | Upgrade
|
| Debt / FCF Ratio | 0.07 | 0.06 | 0.25 | 0.09 | 0.06 | 0.21 | Upgrade
|
| Net Debt / Equity Ratio | -0.69 | -0.70 | -0.61 | -0.60 | -0.53 | -0.54 | Upgrade
|
| Net Debt / EBITDA Ratio | -9.16 | -8.10 | -11.28 | -6.65 | -5.16 | -7.28 | Upgrade
|
| Net Debt / FCF Ratio | -10.54 | -4.76 | -10.98 | -6.17 | -4.06 | -8.26 | Upgrade
|
| Asset Turnover | 0.39 | 0.40 | 0.46 | 0.44 | 0.43 | 0.43 | Upgrade
|
| Inventory Turnover | 3.30 | 3.39 | 3.68 | 3.34 | 3.21 | 3.44 | Upgrade
|
| Quick Ratio | 12.94 | 15.71 | 15.74 | 9.54 | 10.89 | 12.96 | Upgrade
|
| Current Ratio | 13.72 | 16.57 | 16.99 | 10.24 | 11.71 | 14.02 | Upgrade
|
| Return on Equity (ROE) | 10.31% | 12.82% | 5.73% | 7.71% | 10.05% | 3.13% | Upgrade
|
| Return on Assets (ROA) | 2.90% | 3.43% | 1.18% | 3.31% | 4.16% | 2.15% | Upgrade
|
| Return on Invested Capital (ROIC) | 15.58% | 16.29% | 4.63% | 10.55% | 12.97% | 7.99% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.70% | 5.50% | 1.90% | 5.60% | 6.80% | 3.60% | Upgrade
|
| Earnings Yield | 13.53% | 15.49% | 8.21% | 9.53% | 7.79% | 1.92% | Upgrade
|
| FCF Yield | 9.01% | 18.57% | 8.16% | 12.02% | 10.54% | 3.90% | Upgrade
|
| Dividend Yield | 3.20% | 3.30% | 4.33% | 3.99% | 2.78% | 2.28% | Upgrade
|
| Payout Ratio | 24.46% | 20.36% | 48.86% | 38.43% | 30.65% | 136.11% | Upgrade
|
| Buyback Yield / Dilution | - | - | 0.73% | 2.50% | 0.32% | 4.25% | Upgrade
|
| Total Shareholder Return | 3.20% | 3.30% | 5.07% | 6.49% | 3.10% | 6.54% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.